Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512406 · ClinicalTrials.gov registry record
Sensory Processing in Tourette Syndrome
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 18
- Enrollment target
NCT02512406: Completed study, sponsored by University of Florida.
NCT02512406 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02512406 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about how patients with Tourette Syndrome deal with sensory stimuli in their environment such as bright lights, loud noises, physical sensations such as shirt tags, etcetera. We will compare responses of patients with Tourette Syndrome to those without Tourette Syndrome. The study aims to better characterize sensory processing abnormalities by sensory modality: The investigators will use a measuring tool based on Dunn's 1997 model of sensory processing, the Sensory Profile, which will allow the investigator to characterize both registration and response to external stimuli, as well as to delineate which sensory modalities are affected. Identifying which sensory modalities are most affected may guide future research into the pathophysiology of sensory processing abnormalities in TS. The investigators also aim to correlate sensory processing abnormalities with the presence of Obsessive Compulsive Disorder (OCD), Attention-deficit/hyperactivity disorder (ADHD) , and autism spectrum disorders.
Primary Outcome
60 item questionnaire administered to participants age 6-10 with questions pertaining to sensory processing categories of Taste/Smell, Movement, Visual, Touch, Activity Level, and Auditory. Scores are tallied for each category. Results are plotted along an x and y-axis with one axis being perception or stimulus (low registration to sensory sensitivity) and the other being response to stimulus (sensation seeking to sensation avoiding). Each category is plotted along this axis and compared to norm
Interventions
- OTHER The Sensory Profile
- OTHER The Adult/Adolescent Sensory Profile
- OTHER Children's Yale-Brown Obsessive Compulsive Scale
- OTHER Yale-Brown Obsessive Compulsive Scale
- OTHER Yale Global Tic Severity Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-06-02 |
What the finished NCT02512406 record still lists
NCT02512406 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which The Sensory Profile is the first listed.
NCT02512406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02512406 about?
NCT02512406 is a clinical study titled "Sensory Processing in Tourette Syndrome". The purpose of this study is to learn more about how patients with Tourette Syndrome deal with sensory stimuli in their environment such as bright lights, loud noises, physical sensations such as shirt tags, etcetera. We will compare responses of patients with Tourette Syndrome to those without Tour...
What is the current status of trial NCT02512406?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2015-08. Estimated completion is 2016-06-02.
What interventions are being tested in trial NCT02512406?
The interventions under investigation include: The Sensory Profile (OTHER), The Adult/Adolescent Sensory Profile (OTHER), Children's Yale-Brown Obsessive Compulsive Scale (OTHER), Yale-Brown Obsessive Compulsive Scale (OTHER), Yale Global Tic Severity Scale (OTHER).
Who is sponsoring clinical trial NCT02512406?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia